LTRN - Lantern Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LTRN is currently covered by 1 analysts with an average price target of $9.57. This is a potential upside of $6 (168.07%) from yesterday's end of day stock price of $3.57.

Lantern Pharma's activity chart (see below) currently has 1 price targets and 8 ratings on display. The stock rating distribution of LTRN is 80% BUY and 20% HOLD.

Stock Analyst Price Targets - Review

Highest price target for LTRN is $5, Lowest price target is $4, average price target is $11.

Most recent stock forecast was given by MICHAEL KING from HCWAINWRIGHT on 10-Aug-2023. First documented stock forecast 07-Oct-2021.

Best performing analysts who are covering LTRN - Lantern Pharma:

Michael King

Currently out of the existing stock ratings of LTRN, 4 are a BUY (80%), 1 are a HOLD (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$11

$7.34 (200.55%)

$11

1 years 7 months 1 days ago
(10-Aug-2023)

0/5 (0%)

$6 (120.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LTRN (Lantern Pharma) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on LTRN (Lantern Pharma) with a proven track record?

MICHAEL KING

Which analyst has the most public recommendations on LTRN (Lantern Pharma)?

Michael King has 7 price targets and 7 ratings on LTRN

Which analyst is the currently most bullish on LTRN (Lantern Pharma)?

Michael King with highest potential upside - $7.34

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?